期刊文献+

抗早产药药理学评价模型

Pharmacologic models of drugs against premature delivery
下载PDF
导出
摘要 文章综述了抗早产药的药理学评价模型。其中包括大鼠已启动分娩过程的阻滞模型 ;延迟晚期妊娠大鼠分娩启动模型 ;脂多糖诱导小鼠早产的拮抗模型 ;白介素诱导小鼠早产的拮抗模型和 15 The animal models for pharmacologic assessment of drugs against premature delivery arereviewed, which include the measure of spontaneous delivery time between the first and the second pups in term pregnancy rats, the delay in the onset of labor in rats and premature delivery artificially induced by lipopolysaccharide, interleukin 1 α and prostaglandin F 2α in mice.
出处 《中国药理学通报》 CAS CSCD 北大核心 2002年第3期253-255,共3页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助课题 No 3 9670 75 7
关键词 抗早产药 动物模型 脂多糖 白介素-1Α 15-甲基前列腺素F2α tocolytic agents animal models lipopolysaccharide interleukin 1α prostaglandin F 2α
  • 相关文献

参考文献2

二级参考文献10

  • 1[1] Rizzo G, Capponi A, Arduini D, et al. The value of fetal fibronectin in cervical and vaginal secretions and of ultrasonographic examinat ion of the uterine cervix in predicting premature delivery for patients with pre term labor and intact membranes[J]. Am J Obstet Gynecol, 1996,175(5):1146-1 151.
  • 2[2] Joffe GM, Jacquees D, Burton R, et al. Impact of the fetal fibr onectin assay on admissions for preterm labor[J]. Am J Obstet Gynecol, 1999, 180(3):581-586.
  • 3[3] Garcia AA, Ayala MJ, Izquierdo PJ, et al. Presence of fetal fi bronection in cervico-vaginal secretion as predictor of premature labor[J]. Ginecol Obstet Mex,1999,1(67):23-28.
  • 4[4] Smith R, Mesiano S, Chan EC, et al. Corticotropin-releasing hor mone directly and preferentially stimulates dehydroepiandrosterone sulfate secre tion by human fetal adrenal cortisol cells[J]. J Clin Endocrinol Metab,1998, 83(8):2916-2920.
  • 5[5] Hobel CJ,Christine DS,Scott C,et al. Materal plasma corticotropi n-releasing hormone associated with stress at 20 weeks'gestation in pregnancies ending in preterm delivery[J]. Am J Obstet Gynecol,1999,180(1):S257-S263.
  • 6[6] McGregor JA,Jackson GM, Lachelin GC, et al. A prospective trial :salivary estriol as risk assessment for preterm labor[J].Am J Obstet Gyn ecol, 1995,173(4):1337-1342.
  • 7[7] Dudley DJ. Immunoendocrinology of preterm labor:the link beteween co rticotropin-releasing hormone and inflammation[J]. Am J Obstet Gynecol,1999, 180(1):S251-S256.
  • 8[8] Schanler R, Smith LJ, Burns P. Effects of long term maternal i ntravenous magnesium sulfate therapy on neonatal calcium metabolism and bone min eral content[J]. Gynecol Obstet Invest,1997,43(4):326-341.
  • 9[9] Kramer W, Saade G, Belfort M, et al. A randomized double-blin d st udy comparing the fetal effects of sulindac to terbutaline during the managemen t of preterm labor[J]. Am J Obstet Gynecol, 1999,180(2Pt1):396-401.
  • 10[10] Kobayashi M,Akahane M,Minami K,et al. Role of oxytocin in the initiation of term and preterm labor in rats: changes in oxytocin receptor densi ty and plasma oxytocin concentration and the effect of an oxytocin antagonist,L -366 509[J]. Am J Obstet Gynecol,1999,180(3 Pt 1):621-627.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部